Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma

Journal of Neuro-Oncology

Volumn 72, Issue 2, 2005, Pages 107-113

  Yamanaka, Ryuya ^a   Honma, Junpei ^a   Tsuchiya, Naoto ^a   Yajima, Naoki ^a   Kobayashi, Tsutomu ^a   Tanaka, Ryuichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

CTL; Dendriticcell; IL 18; Immunotherapy; Malignant glioma; Tumor lysate

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTERLEUKIN 10; INTERLEUKIN 18; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; BRAIN CELL; CANCER INHIBITION; CANCER PATIENT; CASE REPORT; CELL ISOLATION; CELL LYSATE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOBLAST; MALE; TH1 CELL; TUMOR CELL; TUMOR CELL LINE;

AGED; BRAIN NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; FEMALE; GENES, MHC CLASS I; GLIOMA; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-18; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 20444424186     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-3550-9     Document Type: Article

References (31)

1. G Dranoff E Jaffee A Lazenby P Golumbek H Levitsky K Brose V Jackson H Hamada D Pardoll RC Mulligan 1993 Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 90 3539-3543 1:CAS:528:DyaK3sXktVKqt78%3D 8097319
2. JH Sampson GE Archer DM Ashley HE Fuchs LP Hale G Dranoff DD Bigner 1996 Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system Proc Natl Acad Sci USA 93 10399-10404 10.1073/pnas.93.19.10399 1:CAS:528:DyaK28XlslGku7g%3D 8816812
3. JS Yu CJ Wheeler PM Zeltzer H Ying DN Finger PK Lee WH Yong F Incardona RC Thompson MS Riedinger W Zhang RM Prins KL Black 2001 Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T cell infiltration Cancer Res 61 842-847 1:CAS:528:DC%2BD3MXhsFSrtLs%3D 11221866
4. H Aoki M Mizuno A Natsume T Tsugawa K Tsujimura T Takahashi J Yoshida 2001 Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor Cancer Immunol Immunother 50 463-468 10.1007/s002620100220 1:CAS:528:DC%2BD38Xjsl2jtw%3D%3D 11761440
5. AB Heimberger LE Crotty GE Archer RE McLendon A Friedman G Dranoff DD Bigner JH Sampson 2000 Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma J Neuroimmunol 103 16-25 10.1016/S0165-5728(99)00172-1 1:CAS:528:DC%2BD3cXltVensg%3D%3D 10674985
6. O Insug G Ku HC Ertl M Blaszczyk-Thurin 2002 A dendritic cell vaccine induces protective immunity to intracranial growth of glioma Anticancer Res 22 613-621 1:CAS:528:DC%2BD38XktF2ntLo%3D 12014629
7. T Kikuchi Y Akasaki M Irie S Homma T Abe T Ohno 2001 Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells Cancer Immunol Immunother 50 337-344 10.1007/ s002620100205 1:STN:280:DC%2BD3MrntVSjtQ%3D%3D 11676393
8. LM Liau KL Black RM Prins SN Sykes PL DiPatre TF Cloughesy DP Becker JM Bronstein 1999 Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens J Neurosurg 90 1115-1124 1:STN:280:DyaK1M3nslOlsQ%3D%3D 10350260
9. R Yamanaka SA Zullo R Tanaka M Blaese KG Xanthopoulos 2001 Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA J Neurosurg 94 474-481 1:CAS:528:DC%2BD3MXhvFKgtbY%3D 11235953
10. C Castelli WJ Storkus MJ Maeurer DM Martin EC Huang BN Pramanik TL Nagabhushan G Parmiani MT Lotze 1995 Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ T cells J Exp Med 181 363-368 10.1084/jem.181.1.363 1:CAS:528:DyaK2MXisl2rs70%3D 7807017
11. AL Cox J Skipper Y Chen RA Henderson TL Darrow J Shabanowitz VH Engelhard DF Hunt CL Slingluff 1994 Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines Science 264 716-719 1:CAS:528:DyaK2cXltVKisbc%3D 7513441
12. GE Peoples PS Goedegeboure R Smith DC Linehan I Yoshino TJ Eberlein 1995 Breast and ovarian-cancer specific cytotoxic T lymphocytes recognize the same HER/2neu-derived peptide Proc Natl Acad Sci USA 92 432-436 1:CAS:528:DyaK2MXjt12qsbo%3D 7831305
13. I Yoshino PS Goedegeboure GE Peoples AS Parikh JM DiMain HK Lyerly AF Gazdar TJ Eberlein 1994 HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer Cancer Res 54 3387-3390 1:CAS:528:DyaK2cXksFGntbc%3D 7912166
14. RM Steinman 1991 The dendritic cell system and its role in immunogenicity Ann Rev Immunol 9 271-296 10.1146/ annurev.iy.09.040191.001415 1:CAS:528:DyaK3MXmt12kurc%3D
15. JW Young K Inaba 1996 Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity J Exp Med 183 7-11 1:CAS:528:DyaK28XjsVCiug%3D%3D 8551246
16. N Romani S Gruner D Brang E Kampgen A Lenz B Trockebacher GO Konwalinka P Fritsch RM Steinman G Schuler 1994 Proliferating dendritic cell progenitors in human blood J Exp Med 180 83-93 1:CAS:528:DyaK2cXkvVSrurw%3D 8006603
17. JS Yu CJ Wheeler PM Zeltzer H Ying PK Lee F Incardona WH Yong RC Thompson MS Riedinger KL Black 2001 Dendritic cell immunotherapy for patients with glioblastoma multiforme and anaplastic astrocytoma Proc Am Assoc Cancer Res Abstr 42 274
18. R Yamanaka T Abe N Yajima N Tsuchiya J Homma T Kobayashi M Narita M Takahashi R Tanaka 2003 Vaccination of recurrent glioma patients with tumor-lysate pulsed dendritic cells elicits immune responses: Results of clinical phase I/II trial Br J Cancer 89 1172-1179 10.1038/ sj.bjc.6601268 1:CAS:528:DC%2BD3sXns1Cmu7k%3D 14520441
19. CL Nastala HD Edington TG McKinney H Tahara MA Nalesnik MJ Brunda MK Gately SF Wolf RD Schreiber WJ Storkus 1994 Recombinant IL-12 administration induces tumor regression in association with IFN- production J Immunol 153 1697-1706 1:CAS:528:DyaK2cXlslOgsbk%3D 7913943
20. F Ossendorp E Mengede M Camps R Filius CJ Melief 1998 Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors J Exp Med 187 693-702 10.1084/jem.187.5.693 1:CAS:528:DyaK1cXhs1antb0%3D 9480979
21. MJ Micallef K Yoshida S Kawai T Hanaya K Kohno S Arai T Tanimoto K Torigoe M Fujii M Ikeda M Kurimoto 1997 In vivo antitumor effects of murine interferon - inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites Cancer Immunol Immunother 43 361-367 10.1007/s002620050345 1:CAS:528:DyaK2sXisVeitr4%3D 9067408
22. R Yamanaka N Yajima T Abe N Tsuchiya J Homma M Narita M Takahashi R Tanaka 2003 Dendritic cell-based glioma immunotherapy (Review) Int J Oncol 23 5-15 1:CAS:528:DC%2BD3sXltFahsb4%3D 12792771
23. T Kobayashi R Yamanaka J Homma N Tsuchiya N Yajima S Yoshida R Tanaka 2003 Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma Cancer Immunol Immunother 52 632-637 10.1007/s00262-003-0408-5 1:CAS:528:DC%2BD3sXnsV2lu7k%3D 12827308
24. M Onodera A Yachie DM Nelson H Welchlin RA Morgan RM Blaese 1997 A simple and reliable method for screening retroviral producer clones without selectable markers Hum Gene Ther 8 1189-1194 1:CAS:528:DyaK2sXksF2ntrY%3D 9215736
25. A Anichini R Mortarini C Maccalli P Squarcina K Fleischhauer L Mascheroni G Parmiani 1996 Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma J Immunol 156 208-217 1:CAS:528:DyaK28XlsVOk 8598464
26. D Boczkowski SK Nair D Snyder E Gilboa 1996 Dendritic cells pulsed with RNA are potent antigen presenting in vitro and in vivo J Exp Med 184 465-472 10.1084/jem.184.2.465 1:CAS:528:DyaK28XltVCrs74%3D 8760800
27. SK Nair D Snyder BT Rouse E Gilboa 1997 Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts Int J Cancer 70 706-715 10.1002/ (SICI)1097-0215(19970317)70:6<706::AID-IJC13>3.0.CO;2-7 1:STN:280:ByiB2M%2FpslQ%3D 9096653
28. L Zitvogel JI Majordomo T Tjandrawan AB DeLeo MR Clarke MT Lotze WJ Storkus 1996 Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med 183 87-97 10.1084/jem.183.1.87 1:CAS:528:DyaK28XjsVChtA%3D%3D 8551248
29. S Romagnani 1992 Human TH1 and TH2 subsets: Regulation of differentiation and role in protection and immunopathology Int Arch Allergy Immunol 98 279-285 1:STN:280:ByyD2cvmtVY%3D 1422257
30. P Ghosh KL Komschlies M Cippitelli DL Longo J Subleski J Ye A Sica HA Young RH Wiltrout AC Ochoa 1995 Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth J Natl Cancer Inst 87 1478-1483 1:CAS:528:DyaK2MXpsVSms74%3D 7674335
31. M Kohyama K Saijyo M Hayasida T Yasugi M Kurimoto T Ohno 1998 Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18 Jpn J Cancer Res 89 1041-1046 1:CAS:528:DyaK1cXnt1Oju78%3D 9849583